ZA200702066B - Halogenated benzmide derivatives - Google Patents

Halogenated benzmide derivatives

Info

Publication number
ZA200702066B
ZA200702066B ZA200702066A ZA200702066A ZA200702066B ZA 200702066 B ZA200702066 B ZA 200702066B ZA 200702066 A ZA200702066 A ZA 200702066A ZA 200702066 A ZA200702066 A ZA 200702066A ZA 200702066 B ZA200702066 B ZA 200702066B
Authority
ZA
South Africa
Prior art keywords
benzmide
halogenated
derivatives
halogenated benzmide
benzmide derivatives
Prior art date
Application number
ZA200702066A
Other languages
English (en)
Inventor
Rossignol Jean Francois
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of ZA200702066B publication Critical patent/ZA200702066B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA200702066A 2004-09-09 2005-09-06 Halogenated benzmide derivatives ZA200702066B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60835404P 2004-09-09 2004-09-09

Publications (1)

Publication Number Publication Date
ZA200702066B true ZA200702066B (en) 2008-08-27

Family

ID=36060542

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702066A ZA200702066B (en) 2004-09-09 2005-09-06 Halogenated benzmide derivatives

Country Status (26)

Country Link
US (3) US7285567B2 (ja)
EP (1) EP1789040B1 (ja)
JP (1) JP4998852B2 (ja)
KR (1) KR101344984B1 (ja)
CN (1) CN101035531B (ja)
AP (1) AP2451A (ja)
AU (1) AU2005285157B2 (ja)
BR (1) BRPI0515089B8 (ja)
CA (1) CA2580347C (ja)
CY (1) CY1118689T1 (ja)
DK (1) DK1789040T3 (ja)
EA (1) EA012606B1 (ja)
ES (1) ES2559672T3 (ja)
HK (1) HK1106139A1 (ja)
HR (1) HRP20151439T1 (ja)
HU (1) HUE026613T2 (ja)
IL (2) IL181849A (ja)
ME (1) ME02370B (ja)
MX (1) MX2007002969A (ja)
PL (1) PL1789040T3 (ja)
PT (1) PT1789040E (ja)
RS (1) RS54453B1 (ja)
SI (1) SI1789040T1 (ja)
UA (1) UA90864C2 (ja)
WO (1) WO2006031566A2 (ja)
ZA (1) ZA200702066B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533865A (en) * 2002-02-12 2006-02-24 Smithkline Beecham Corp Nicotinamide derivates useful as p38 inhibitors
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20070015803A1 (en) * 2005-04-12 2007-01-18 Romark Laboratories L.C. Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
MX2008008723A (es) * 2006-01-09 2008-09-26 Romark Lab Lc Tratamiento de la hepatitis viral.
JP5676258B2 (ja) 2007-08-03 2015-02-25 ロマーク ラボラトリース,エル.シー. アルキルスルホニル置換チアゾリド化合物
US8524278B2 (en) 2009-02-13 2013-09-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
JP5918124B2 (ja) 2009-05-12 2016-05-18 ロマーク ラボラトリーズ エル.シー. ハロアルキルヘテロアリールベンズアミド化合物
MX341877B (es) 2009-06-26 2016-09-06 Romark Laboratories L C * Compuestos y métodos para tratar influenza.
CN102335171B (zh) * 2010-07-27 2013-09-11 中国农业科学院上海兽医研究所 一类n-(2-噻唑)苯甲酰胺衍生物的应用
BR112013029505A2 (pt) 2011-05-16 2020-01-07 Romark Laboratories L.C. Composição farmacêutica, e, uso de um composto
US9650369B2 (en) * 2012-09-28 2017-05-16 Xavier University Of Louisiana Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease
JP6633092B2 (ja) 2014-11-11 2020-01-22 ロマーク ラボラトリーズ,リミティド カンパニー チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法
PT3436074T (pt) 2016-03-31 2020-08-21 Romark Laboratories Lc Compostos tiazolida para tratamento de infeções virais
SI3442580T1 (sl) 2016-04-11 2021-01-29 Genfit Metode zdravljenja holestatičnih in fibrotičnih bolezni
US11173149B2 (en) 2017-04-18 2021-11-16 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase A3
WO2022020243A1 (en) 2020-07-20 2022-01-27 Romark Laboratories L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
AU2021333566A1 (en) 2020-08-24 2023-03-16 Romark Laboratories L.C. Use of thiazolides against coronaviruses
WO2022218239A1 (zh) * 2021-04-12 2022-10-20 杜心赟 新型噻唑类化合物及其制备方法和用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1276663A (en) * 1968-12-24 1972-06-07 Ici Ltd Stimulation of plant growth
ZA712295B (en) * 1970-04-15 1972-01-26 Shell Int Research Fungicidal compounds
GB1437800A (en) 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
JPS60205454A (ja) * 1984-03-29 1985-10-17 Mitsubishi Paper Mills Ltd 電子写真感光体
US5169846A (en) 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
SK281949B6 (sk) * 1994-04-13 2001-09-11 Jean-Francois Rossignol Derivát benzamidu, farmaceutický prostriedok, ktorý ho obsahuje, a použitie
US5578621A (en) 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
DE19528046A1 (de) * 1994-11-21 1996-05-23 Bayer Ag Triazolyl-Derivate
US5935591A (en) * 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
IL152451A0 (en) * 2000-04-28 2003-05-29 Sankyo Co 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
EP1301378A1 (en) * 2000-07-14 2003-04-16 Breed Automotive Technology, Inc. Energy absorbing seat belt retractor
EP1844766B1 (en) 2000-12-18 2012-04-18 Institute of Medicinal Molecular Design, Inc. Inhibitors against the production and release of inflammatory cytokines
JP2003064056A (ja) * 2001-08-27 2003-03-05 Sankyo Co Ltd アミド誘導体
WO2003035602A1 (fr) * 2001-10-25 2003-05-01 Sankyo Company, Limited Modulateurs lipidiques
WO2003103665A1 (ja) * 2002-06-06 2003-12-18 株式会社医薬分子設計研究所 抗アレルギー薬
US6737382B1 (en) * 2002-10-23 2004-05-18 Nippon Soda Co. Ltd. Insecticidal aminothiazole derivatives
AU2005206571B8 (en) * 2004-01-23 2010-09-02 Amgen Inc. Compounds and methods of use
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives

Also Published As

Publication number Publication date
MX2007002969A (es) 2008-02-15
BRPI0515089B8 (pt) 2021-05-25
ES2559672T3 (es) 2016-02-15
AU2005285157B2 (en) 2009-07-16
IL181849A (en) 2013-11-28
US20060089396A1 (en) 2006-04-27
US7645783B2 (en) 2010-01-12
AU2005285157A1 (en) 2006-03-23
AP2451A (en) 2012-08-31
IL203061A (en) 2013-04-30
EP1789040A2 (en) 2007-05-30
WO2006031566A3 (en) 2006-06-08
KR101344984B1 (ko) 2013-12-24
EA012606B1 (ru) 2009-10-30
UA90864C2 (en) 2010-06-10
EA200700432A1 (ru) 2007-10-26
KR20070052330A (ko) 2007-05-21
CN101035531A (zh) 2007-09-12
CA2580347C (en) 2013-12-10
BRPI0515089B1 (pt) 2019-07-16
US7285567B2 (en) 2007-10-23
US7550493B2 (en) 2009-06-23
IL181849A0 (en) 2007-07-04
SI1789040T1 (sl) 2016-02-29
US20080096941A1 (en) 2008-04-24
HRP20151439T1 (hr) 2016-02-12
JP2008512474A (ja) 2008-04-24
DK1789040T3 (en) 2016-02-01
BRPI0515089A (pt) 2008-07-08
CA2580347A1 (en) 2006-03-23
EP1789040B1 (en) 2015-12-23
PT1789040E (pt) 2016-02-19
ME02370B (me) 2016-06-20
PL1789040T3 (pl) 2016-04-29
RS54453B1 (en) 2016-06-30
AP2007003950A0 (en) 2007-04-30
CN101035531B (zh) 2013-01-02
HK1106139A1 (zh) 2008-03-07
HUE026613T2 (hu) 2016-06-28
CY1118689T1 (el) 2017-07-12
US20080097106A1 (en) 2008-04-24
WO2006031566A2 (en) 2006-03-23
EP1789040A4 (en) 2009-09-02
JP4998852B2 (ja) 2012-08-15

Similar Documents

Publication Publication Date Title
ZA200702066B (en) Halogenated benzmide derivatives
TWI369356B (en) Tetrahydropyridoindole derivatives
IL180481A0 (en) Aryl-pyridine derivatives
HK1105971A1 (en) Pyrrazolo-pyrimidine derivatives
IL179603A0 (en) Pyrrolopyridine derivatives
AP2074A (en) New 4-benzylidene-piperidin derivatives
IL183140A0 (en) Substituted benzoquinolizine derivatives
ZA200703172B (en) Imidazo-benzodiazepine derivatives
IL177204A0 (en) Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
HK1101638A1 (en) New pyridothienopyrimidine derivatives
HK1100002A1 (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
HK1100775A1 (en) 4-Amino-5-cyanopyrimidine derivatives
GB0414272D0 (en) OsK1 derivatives
IL182001A0 (en) 2-acylaminothiazole derivatives
ZA200609864B (en) Pyrrolopyridine derivatives
GB0405905D0 (en) Azaquinazoline derivatives
GB0422397D0 (en) 3-Cyano-Quinoline derivatives
HUP0402371A2 (en) Novel 125-i-labeled amino-quinoline derivatives